QualityStocksNewsBreaks Archives - Page 196 of 1582

WednesdayJul 02, 2025 9:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Joins White House Advisory Council, Expands VerifyU(TM) Applications

Datavault AI (NASDAQ: DVLT), a leader in AI data experience, valuation, and monetization, announced its appointment to the White House Experience Advisory Council, where it will support efforts to modernize how the Executive Mansion shares and preserves American history, while also expanding applications of its VerifyU(TM) platform for identity ownership, digital licensing, NIL compliance, immersive acoustic delivery, and high-performance computing across sports, healthcare, government, and education. To view the full press release, visit https://ibn.fm/S4Blp About Datavault AI Inc. Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s…

WednesdayJul 02, 2025 9:00 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap Index Following June Reconstitution

Safe Pro Group (NASDAQ: SPAI) an emerging provider of AI-powered security and threat detection solutions, has been added to the Russell Microcap(R) Index, effective after market close on June 27, 2025, as part of the index's annual reconstitution. The inclusion reflects the company's growing market profile and will increase its visibility among institutional investors and index-tracking funds. Safe Pro Chairman and CEO Dan Erdberg called the milestone a key step in the company’s expansion, citing the relevance of its AI and drone technologies in defense, security, and humanitarian applications. To view the full press release, visit https://ibn.fm/5tjnF About Safe Pro…

TuesdayJul 01, 2025 9:40 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution

Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a reflection of market recognition and momentum behind the company’s AVERSA pipeline, particularly AVERSA Fentanyl, which has potential peak annual U.S. sales between $80 million and $200 million. Russell indexes, maintained by FTSE Russell, benchmark approximately $10.6 trillion in assets and are widely used by investment managers and institutions. To view the full report, visit https://ibn.fm/Vcsgx About Nutriband Inc. Nutriband is primarily engaged in the development…

TuesdayJul 01, 2025 9:20 am

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Restructures $7 Million in Legacy Debt, Secures Repurchase Option

Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and legacy debt obligations through an agreement with a new third-party investor, who acquired all outstanding notes previously held by the Company’s largest creditor, T&K Zarro, LLC. The transaction consolidates five debt instruments totaling over $7 million and grants GTVH the exclusive right to repurchase the full balance for $4 million, offering a significant discount. The move simplifies GTVH’s balance sheet, supports disciplined growth and strengthens financial positioning. To view the full press release, visit https://ibn.fm/ynhAO About Golden Triangle Ventures Inc. Golden Triangle Ventures is a…

TuesdayJul 01, 2025 9:10 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Amends Payment Schedule for Iska Iska Interest, Updates Adjacent Property Agreement

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) has reached a mutual agreement with Empresa Minera Villegas S.R.L. to amend the payment terms for acquiring 100% interest in the Iska Iska silver-tin polymetallic project in southern Bolivia. Of the remaining US$4.45 million owed, US$1.8 million in exploration spending on the adjacent Mina Casiterita property will be credited, with cash payments of US$1 million due July 15, 2025, and US$1.65 million due January 6, 2026. The related Mina Casiterita and Mina Hoyada option agreement has also been revised, calling for a US$1.8 million payment within 12 months of securing mining rights…

TuesdayJul 01, 2025 9:00 am

QualityStocksNewsBreaks – Channelchek by Noble Highlights Aurania Resources (TSXV: ARU) as 2D Inversion Reveals Six Conductive Anomalies at Awacha

Channelchek, a Noble Financial Group, Inc. product and service, reports that Aurania Resources (TSXV: ARU) identified six highly conductive anomalies at its Awacha porphyry copper target in Ecuador using updated two-dimensional inversion technology on 2021 MobileMT survey data. The advanced 2.5D algorithm, which factors in local topography, provided enhanced subsurface mapping and confirmed deep-rooted conductivity zones beginning 250 meters below surface. These anomalies are considered promising for porphyry copper exploration due to their correlation with conductive sulphide mineralization and porphyry-related alteration. To access the full report, visit https://ibn.fm/uO04N About Noble Capital Markets Established in 1984, Noble Capital Markets is an…

MondayJun 30, 2025 3:45 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advancing Novel Immunotherapy to Combat Antibiotic Resistance

Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections in the face of escalating antibiotic resistance. The company’s SGX943 therapy “is based on dusquetide, an Innate Defense Regulator (‘IDR’) that modulates the body’s immune response rather than directly targeting bacteria. By enhancing the innate immune system, SGX943 promotes the clearance of infections and reduces inflammation, offering a broad-spectrum approach to bacterial infections,” reads a recent article. “The company’s portfolio encompasses both specialized biotherapeutics and public health solutions, targeting areas with significant unmet medical needs.” To view the full article,…

MondayJun 30, 2025 2:42 pm

QualityStocksNewsBreaks – Vivakor Inc. (NASDAQ: VIVK) Poised for Opportunity at the Nexus of Energy and Innovation

As governments, consumers, and investors demand cleaner practices and corporate accountability, companies are being urged to innovate and adapt—or risk falling behind. Vivakor (NASDAQ: VIVK), a vertically integrated energy infrastructure and environmental services company, is positioned for this challenge. Engaged in the transportation, storage, reuse, and remediation of oilfield fluids and waste, Vivakor is proving that environmental responsibility and profitability are not mutually exclusive. Looking ahead, “Vivakor is focused on expanding its environmental services segment, investing in infrastructure that enhances waste oil processing, and advancing technologies that reduce emissions and environmental impact. By positioning itself at the intersection of energy production…

MondayJun 30, 2025 1:12 pm

QualityStocksNewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. “Lantern Pharma’s AI-driven RADR(R) platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline,” reads a recent article. “The company has three lead drug candidates in clinical development, targeting major oncology markets including non-small cell lung cancer (‘NSCLC’), triple-negative breast cancer (‘TNBC’), and non-Hodgkin’s lymphoma (‘NHL’)… Starlight Therapeutics extends Lantern’s footprint into…

MondayJun 30, 2025 9:30 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs

Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical analysis plan (SAP) for evaluating neurofilament light (NfL) biomarker data from its Expanded Access Protocol for ALS. The company has resubmitted a revised SAP and anticipates FDA acceptance this summer, with NfL analyses scheduled for early Q4 2025 to support a potential NDA submission under the accelerated approval pathway. Clene also confirmed two additional FDA meetings in Q3 2025: one to assess long-term ALS survival data for accelerated approval consideration and another End-of-Phase 2 Type B meeting to review…

Site Search

Company Search

Category: QualityStocksNewsBreaks